FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely immunology, and may be used for increasing proliferative activity of peripheral blood lymphocytes. That is ensured by applying a synthetic agent in a medicinal base. The synthetic agent is presented by synthetic peptides having the structure LYS GLY PRO LEY THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO and THR NLE NLE ALA SER HIS TYR LYS GLN HIS CYS PRO, of molecular weight 1794 to 1397 Da, in the concentrations of 10-4 to 10-5 mg/ml of the medicinal base which is presented by physiologic saline to be applied once a day.
EFFECT: use of the given method enables higher proliferative activity of lymphocytes required for pathogenetic therapy of the diseases.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF INCREASING REPAIR ACTIVITY | 2010 |
|
RU2455020C2 |
| METHOD OF INCREASING BACTERICIDAL ACTIVITY | 2010 |
|
RU2448725C2 |
| SYNTHETIC POLYPEPTIDE, METHOD FOR ITS PRODUCTION AND AGENT FOR CULTIVATION ON ITS BASE | 1994 |
|
RU2061699C1 |
| GROWTH STIMULATING AGENT FOR HUMAN BONE MARROW CELLS | 1994 |
|
RU2136308C1 |
| METHOD OF DIAGNOSIS OF HEMOPOIESIS DEPRESSION | 1994 |
|
RU2136307C1 |
| AGENT FOR TREATING PERIODONTITIS AND A METHOD OF TREATING PERIODONTITIS | 2020 |
|
RU2729428C1 |
| ISOLATED ALTERNATIVE INTRACELLULAR SIGNALLING DOMAIN OF CHIMERIC ANTIGEN RECEPTOR AND CHIMERIC ANTIGEN RECEPTOR INCLUDING IT | 2019 |
|
RU2742000C2 |
| CD33, NKG2D AND CD16 BINDING PROTEINS | 2018 |
|
RU2820603C2 |
| COMBINATION OF CELL THERAPY AND IMMUNOMODULATOR COMPOUND | 2018 |
|
RU2777911C2 |
| NK INVOLVING MOLECULES AND METHODS OF THEIR USE | 2019 |
|
RU2812481C2 |
